EthanChase2184

EthanChase2184 Updated 

Panera looks to be forming a textbook cup and handle formation. Watch for the break over $218.00 NASDAQ:PNRA

EthanChase2184 Updated 

Long $AWK. Double bottomed in early November, reversing the bearish trend that began in late June. Solid company with huge potential.

EthanChase2184 Updated 

Bullish on $JNJ. Very, very long term investment.

EthanChase2184 Updated 

Solid retail company -- fourth quarter earnings crushed analysts' estimates and has refocused business plan to compete against Amazon. Also forming ascending triangle pattern. Look for the break over $63.00

EthanChase2184 Updated 

NYSE:WORK Long on $WORK. Solid resistance at the $24 level. Tested multiple times. Like that it rose sharply recently due to increase demand from COVID-19 forced remote work. Good entry point at this pull back. Stop is $21.5 with profit target at the high of the consolidation trend @ $32. P/L ratio ~ 3:1. -Ethan

EthanChase2184 Updated 

NASDAQ:SEDG Long $SEDG. Fundamentals are solid -- "Three-year sales growth rate: +44.33% Three-year earnings growth rate: +37.01%" - SOURCE( www.investopedia.com ) Risks to thesis: 1.) Overall market $SPY trends down due to Corona and/or economic downturn concerns. 2.) Further uncertainty in the oil markets which keeps pushing down the price of oil. In the...

EthanChase2184 Updated 

Good earnings, solid fundamentals, and stable company. Hitting long-term support line.

EthanChase2184 Updated 

NYSE:NEE Long $NEE. If we see market strength, I would expect $SPY to lift up NEE. Small and tight stop loss. Quick trade -- either works or it doesn't. Stop - $219 Target - ~$280 P/L = 3.93:1

EthanChase2184 Updated 

NYSE:DIS Long $DIS. Love the company fundamentally. Corona did us a favor and it is now trading at a massive discount. Entry - $111 Stop - $98.90 Target - $139-$140 P/L: 2.3:1

EthanChase2184 Updated 

NYSE:NAT Long $NAT if it holds that support line. Very tight stop -- either the trade works or it doesn't. Entry - $5.30 Stop - $4.80 Target - 6,7,8 range. P/L: ~4-5:1.

EthanChase2184 Updated 

Potential long. Reported solid phase 1 and phase 2 results for its drug Bempedoic Acid. Amgen is soon releasing results from a similar drug; if results are promising, $ESPR could trend up. Also forming cup and handle pattern.